Location History:
- Cambridge, MA (US) (2000)
- Watertown, MA (US) (2000 - 2006)
- Belmont, MA (US) (1998 - 2017)
- Montreal, CA (2014 - 2018)
Company Filing History:
Years Active: 1998-2018
Title: **The Innovative Contributions of Louis Plamondon**
Introduction
Louis Plamondon is a notable inventor based in Belmont, MA, USA, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 28 patents, he has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents
Among his most recent inventions are several patents related to tetracycline compounds. One specific patent focuses on a compound represented by a specific structural formula and includes details about pharmaceutically acceptable salts. This patent encompasses a pharmaceutical composition that contains the compound and outlines its therapeutic uses. Such developments indicate his dedication to enhancing treatment options available in modern medicine.
Career Highlights
Throughout his career, Louis Plamondon has made notable contributions while working at well-respected companies such as Millennium Pharmaceuticals Limited and Tetraphase Pharmaceuticals, Inc. His work in these organizations has allowed him to leverage his innovative ideas in practical applications, benefiting the pharmaceutical industry significantly.
Collaborations
Collaboration is essential in the field of innovation, and Louis has worked alongside distinguished colleagues, including Julian Adams and Louis Grenier. These partnerships have fostered creativity and supported the development of impactful inventions within the pharmaceutical domain.
Conclusion
In summary, Louis Plamondon represents the spirit of innovation through his extensive patent work and collaborations in the pharmaceutical industry. His contributions, especially in the area of tetracycline compounds, highlight the ongoing efforts to improve healthcare solutions and showcase the vital role of inventors in driving progress in science and technology.